Alain Thibault
Corporate Officer/Principal at ANNEXIN PHARMACEUTICALS AB
Alain Thibault active positions
| Companies | Position | Start | End |
|---|---|---|---|
| ANNEXIN PHARMACEUTICALS AB | Corporate Officer/Principal | 2023-01-17 | - |
Career history of Alain Thibault
Former positions of Alain Thibault
| Companies | Position | Start | End |
|---|---|---|---|
| JOHNSON & JOHNSON | Chief Tech/Sci/R&D Officer | - | - |
Hoffmann-La Roche, Inc.
 Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ. | Director/Board Member | - | - |
| ARGENX SE | Chief Tech/Sci/R&D Officer | 2012-03-18 | - |
National Cancer Institute
 National Cancer Institute Investment Trusts/Mutual FundsMiscellaneous National Cancer Institute provides healthcare services. It specializes in different cancer treatment such as adrenocortical carcinoma, anal cancer, appendix cancer, skin cancer, breast cancer, cardiac tumors, endometrial cancer, and gallbladder cancer. The company was founded in March 1937 and is headquartered in Bethesda, MD. | Chief Tech/Sci/R&D Officer | - | - |
| Director of Finance/CFO | - | - | |
| Corporate Officer/Principal | - | - | |
| University of Virginia | Corporate Officer/Principal | - | - |
Gemin X Pharmaceuticals US, Inc.
 Gemin X Pharmaceuticals US, Inc. BiotechnologyHealth Technology Gemin X Pharmaceuticals US Inc. is engaged in the development of cancer therapeutics. It offers mimetic and telomere capping programs, as well as screening, medicinal chemistry, and preclinical development services. The company was founded by Gordon C. Shore in 1998 and is headquartered in Malvern, PA. | Chief Tech/Sci/R&D Officer | - | - |
| REGENERON PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 2009-09-01 | 2011-12-13 |
| Corporate Officer/Principal | 2007-02-25 | 2009-09-01 |
Training of Alain Thibault
| McGill University | Doctorate Degree |
Statistics
International
| United States | 7 |
| Canada | 2 |
| Netherlands | 2 |
Operational
| Chief Tech/Sci/R&D Officer | 5 |
| Corporate Officer/Principal | 4 |
| Doctorate Degree | 1 |
Sectoral
| Health Technology | 7 |
| Consumer Services | 3 |
| Miscellaneous | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 4 |
|---|---|
| REGENERON PHARMACEUTICALS, INC. | Health Technology |
| ARGENX SE | Health Technology |
| JOHNSON & JOHNSON | Health Technology |
| ANNEXIN PHARMACEUTICALS AB | Health Technology |
| Private companies | 3 |
|---|---|
Gemin X Pharmaceuticals US, Inc.
Gemin X Pharmaceuticals US, Inc. BiotechnologyHealth Technology Gemin X Pharmaceuticals US Inc. is engaged in the development of cancer therapeutics. It offers mimetic and telomere capping programs, as well as screening, medicinal chemistry, and preclinical development services. The company was founded by Gordon C. Shore in 1998 and is headquartered in Malvern, PA. | Health Technology |
National Cancer Institute
National Cancer Institute Investment Trusts/Mutual FundsMiscellaneous National Cancer Institute provides healthcare services. It specializes in different cancer treatment such as adrenocortical carcinoma, anal cancer, appendix cancer, skin cancer, breast cancer, cardiac tumors, endometrial cancer, and gallbladder cancer. The company was founded in March 1937 and is headquartered in Bethesda, MD. | Miscellaneous |
Hoffmann-La Roche, Inc.
Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ. | Health Technology |
- Stock Market
- Insiders
- Alain Thibault
- Experience
